Management of Severe Hypertriglyceridemia in Diabetic Patients
Initial Assessment and Management
- The American College of Cardiology recommends optimizing glycemic control with insulin therapy as the first step for patients with severe hypertriglyceridemia, followed by extreme dietary fat restriction and fibrate therapy 1, 2
- Implementing extreme dietary fat restriction to less than 5% of total calories as fat is recommended until triglyceride levels decrease below 1,000 mg/dL, according to the American College of Cardiology 1, 2, 3
- Completely eliminating added sugars and alcohol consumption is advised for patients with severe hypertriglyceridemia, as recommended by the American College of Cardiology 1, 2, 4
Pharmacological Management
- The American Academy of Family Physicians recommends adding fibrate therapy as first-line medication for severe hypertriglyceridemia to prevent pancreatitis, with a strength of evidence based on clinical guidelines 5, 4, 3
- Prescription omega-3 fatty acids, such as icosapent ethyl or omega-3 acid ethyl esters, may be considered if triglycerides remain elevated despite fibrate therapy, as suggested by the American College of Cardiology 2, 3
- Statins have modest triglyceride-lowering effects and should not be used alone for severe hypertriglyceridemia but may be added for cardiovascular risk reduction, according to the American Academy of Family Physicians 5, 6
Long-Term Management
- Continuing fibrate therapy, such as gemfibrozil 600 mg twice daily or fenofibrate 54-160 mg daily, is recommended for long-term management of severe hypertriglyceridemia, as advised by the American College of Cardiology 3
- Maintaining strict dietary control with limited fat intake and optimizing insulin regimen to maintain good glycemic control are crucial for long-term management, as recommended by the American College of Cardiology 1, 3, 2
Common Pitfalls and Caveats
- The American Academy of Family Physicians warns that statin-fibrate combinations increase the risk of myositis and are generally not recommended unless benefits clearly outweigh risks 4, 3
- The effectiveness of triglyceride-lowering medications is limited when triglycerides are ≥1,000 mg/dL, making insulin therapy and extreme dietary fat restriction crucial initial steps, as emphasized by the American College of Cardiology 1, 2